CADL
#2587
Candel Therapeutics, Inc. - Common Stock
9.6 0 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.61%
Variación mensual
-7.78%
Variación en los últimos 6 meses
+95.92%
Cambio anual
+51.18%
Cierres anteriores
9.7 8
Open
9.7 8
Mínimo
9.6 0
Máximo
9.8 5
Financials
- Market Capitalization 734.58 M
- Employee 55
- Founded 2003
- CEO N/A
- Website www.candeltx.com
- Headquarter Delaware, United States
- FIGI BBG00N0D4Z71
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.85
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2572 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 11.97 USD | +1.44% | -25.14% | +78.66% | +34.80% | 770.15 M USD | ||
| 2581 |  ANNX Annexon, Inc. - common stock | 3.83 USD | -3.28% | -7.49% | -3.53% | +30.72% | 726.09 M USD | ||
| 2588 |  VSTM Verastem, Inc. - Common Stock | 8.07 USD | -2.18% | +1.64% | +9.65% | -11.61% | 730.85 M USD | ||
| 2598 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.64 USD | -0.61% | -5.75% | -17.17% | +13.89% | 729.73 M USD |